N1F(Improved-Nephropathy 1 Formula) Ameliorates Renal Interstitial Fibrosis via Inhibiting Extracellular Matrix Deposition and Regulating the FGF23/P38MAPK/Wnt Pathway-Reference-Cited by-同舟云学术

N1F(Improved-Nephropathy 1 Formula) Ameliorates Renal Interstitial Fibrosis via Inhibiting Extracellular Matrix Deposition and Regulating the FGF23/P38MAPK/Wnt Pathway

Published:2024-05-09 Issue:2 Volume:82 Page:927-943
ISSN:1085-9195
Container-title:Cell Biochemistry and Biophysics
language:en
Short-container-title:Cell Biochem Biophys

Author:

Yu Wenxiu,Zeng Congcong,Wang Chenggong,Jia Sining,Liu Chen,Zeng Yini,Cheng Jinguo

Funder

Zhejiang Provincial Science and Technology Department Project

Zhejiang Provincial Administration of Traditional Chinese Medicine Co-construction of Science and Technology Program Project

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12013-024-01244-6.pdf

Reference46 articles.

1. Nastase, M. V., Zeng-Brouwers, J., Wygrecka, M., & Schaefer, L. (2018). Targeting renal fibrosis: mechanisms and drug delivery systems. Advanced Drug Delivery Reviews, 129, 295–307.

2. Collaboration, G. C. K. D., Tran, K. & Yamada, T. (2020). Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. The Lancet 395, 709–733.

3. Li, L., Fu, H., & Liu, Y. (2022). The fibrogenic niche in kidney fibrosis: components and mechanisms. Nature Reviews Nephrology, 18, 545–557.

4. Wang, Y.-Y., Jiang, H., Pan, J., Huang, X.-R., Wang, Y.-C., & Huang, H.-F., et al. (2017). Macrophage-to-myofibroblast transition contributes to interstitial fibrosis in chronic renal allograft injury. Journal of the American Society of Nephrology, 28, 2053–2067.

5. Humphreys, B. D. (2018). Mechanisms of renal fibrosis. Annual Review of Physiology, 80, 309–326.